The original rise of Viagra presented a significant opportunity for shareholders , but its exclusivity has ended, creating a intricate landscape. Alternative versions have entered the space , diminishing sales and putting a strain on profit percentages . While established pharmaceutical companies maintain a presence in this field , the outlook look